DNA Diagnostics Market Size, Share, Trends, Industry Analysis Report: By Offering, Technology, Specimen, Application, End User, and Region - Market Forecast, 2025

Description

List of Tables

The global DNA diagnostics market size is expected to reach USD 31.31 billion by 2034, according to a new study by Polaris Market Research. The report "DNA Diagnostics Market Size, Share, Trends, Industry Analysis Report: By Offering (Instruments, Reagents & Kits, and Services & Software), Technology, Specimen, Application, End User, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025 - 2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The expansion of the DNA diagnostics market is being driven by the rising prevalence of genetic disorders worldwide. The World Health Organization (WHO) estimated that there are around 10,000 different types of monogenic diseases caused by mutations in a single gene. The global prevalence rate is approximately 10 per 1000 individuals, indicating that between 70 million and 80 million people are affected by genetic disorders. This surge in genetic conditions has created an increased demand for efficient tools to detect and evaluate genetic disorders. Consequently, the growing incidence of rare genetic diseases, hereditary cancers, and inherited metabolic disorders is propelling the advancement of diagnostic technologies, thereby stimulating the DNA diagnostics market.

The market for DNA diagnostics is experiencing significant growth due to the advancements in genomic technology, which have improved the accuracy, speed, and affordability of genetic testing. For instance, in May 2024, BioAro, a genomic research and technology company, launched PanOmiQ, a software that provides real-time insights into the complexities of the human genome. These types of technological enhancements facilitate in-depth genome analysis, resulting in more detailed and dependable diagnostic outcomes. Thus, the ongoing evolution of genomic technologies is driving the growth of the DNA diagnostics market by supporting the development of new diagnostic tools and methods.

Healthcare firms are escalating their financial investments to drive innovation, research, and the advancement of new diagnostic technologies. These investments are empowering companies to progress genomic research, refine testing methodologies, and enhance the precision and dependability of DNA diagnostics. Consequently, company investments are accelerating collaborations with research institutions and the integration of genetic testing into healthcare practices, thereby stimulating the expansion of the global DNA diagnostics market.

DNA Diagnostics Market Report Highlights

The reagents and kits segment is expected to grow with a substantial CAGR in the global market, driven by the development of comprehensive suites tailored for genetic testing.

In 2023, the cancer genetics tests segment accounted for the largest market share because of the increasing prevalence of cancer globally.

In 2023, North America dominated the global DNA diagnostics market in terms of revenue due to the presence of well-established institutions and a robust healthcare infrastructure in the region.

The DNA diagnostics market in China is expected to grow substantially because of the country's increasing investment in biotechnology and healthcare infrastructure.

The global key market players are Abbott; Agilent Technologies, Inc.; Avalon GloboCare Corp.; Beckman Coulter, Inc.; Bio-Rad Laboratories, Inc.; Cepheid; F. Hoffmann-La Roche Ltd; GE HealthCare; Hologic, Inc.; Illumina, Inc.; QIAGEN; Siemens Healthcare Private Limited; and Thermo Fisher Scientific Inc.

Polaris Market Research has segmented the DNA diagnostics market report based on offering, technology, specimen, application, end user, and region:

By Offering Outlook (Revenue - USD Billion, 2019 - 2032)

Instruments
Reagents & Kits
Services & Software

By Technology Outlook (Revenue - USD Billion, 2019 - 2032)

In Situ Hybridization
Mass Spectroscopy
Microarrays
Polymerase Chain Reaction (PCR)
Sequencing
Others

By Specimen Outlook (Revenue - USD Billion, 2019 - 2032)

Blood, Serum, and Plasma
Urine
Others

By Application Outlook (Revenue - USD Billion, 2019 - 2032)

Cancer Genetics Tests
Infectious Diseases DNA Testing
CT/NG Diagnostic
HBV Diagnostic
HCV Diagnostic
HIV Diagnostic
HPV Diagnostic
MRSA Diagnostic
TB Diagnostic
Others
Newborn Genetic Screening
Preimplantation & Reproductive Diagnosis
Non-Infectious Diseases DNA Testing
Cardiovascular Diseases
CNS & PNS Related
Lung, Kidney, Liver & GT Related
Sensory Diseases
Skeletal, Connective, Ectodermal & Dermal DNA Testing
Hematology & Immunology/Identity Diagnostics & Forensics
Pharmacogenomics/Drug Metabolism
Prenatal DNA Carrier Screening
Others

By End User Outlook (Revenue - USD Billion, 2019 - 2032)

Diagnostic laboratories
Hospitals & clinics
Others

By Regional Outlook (Revenue - USD Billion, 2019 - 2032)

North America
US
Canada
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Indonesia
Malaysia
Australia
Rest of APAC
Latin America
Argentina
Brazil
Mexico
Rest of Latin America
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
Rest of MEA

Product Code: PM5229

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global DNA Diagnostics Market Insights

4.1. DNA Diagnostics Market - Market Snapshot
4.2. DNA Diagnostics Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Expansion of DNA Testing Services Are Driving Market Growth
  - 4.2.1.2. Investments by Healthcare Companies Are Propelling Market Size
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. Stringent Regulatory Requirements Affects the Market Expansion
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. DNA Diagnostics Market Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global DNA Diagnostics Market, by Offering

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
5.3. Instruments
- 5.3.1. Global DNA Diagnostics Market, by Instruments, by Region, 2020-2034 (USD billion)
5.4. Reagents & Kits
- 5.4.1. Global DNA Diagnostics Market, by Reagents & Kits, by Region, 2020-2034 (USD billion)
5.5. Services & Software
- 5.5.1. Global DNA Diagnostics Market, by Services & Software, by Region, 2020-2034 (USD billion)

6. Global DNA Diagnostics Market, by Technology

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
6.3. In Situ Hybridization
- 6.3.1. Global DNA Diagnostics Market, by In Situ Hybridization, by Region, 2020-2034 (USD billion)
6.4. Mass Spectroscopy
- 6.4.1. Global DNA Diagnostics Market, by Mass Spectroscopy, by Region, 2020-2034 (USD billion)
6.5. Microarrays
- 6.5.1. Global DNA Diagnostics Market, by Microarrays, by Region, 2020-2034 (USD billion)
6.6. Polymerase Chain Reaction (PCR)
- 6.6.1. Global DNA Diagnostics Market, by Polymerase Chain Reaction (PCR), by Region, 2020-2034 (USD billion)
6.7. Sequencing
- 6.7.1. Global DNA Diagnostics Market, by Sequencing, by Region, 2020-2034 (USD billion)
6.8. Others
- 6.8.1. Global DNA Diagnostics Market, by Others, by Region, 2020-2034 (USD billion)

7. Global DNA Diagnostics Market, by Specimen

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
7.3. Blood, Serum, and Plasma
- 7.3.1. Global DNA Diagnostics Market, by Blood, Serum, and Plasma, by Region, 2020-2034 (USD billion)
7.4. Urine
- 7.4.1. Global DNA Diagnostics Market, by Urine, by Region, 2020-2034 (USD billion)
7.5. Others
- 7.5.1. Global DNA Diagnostics Market, by Others, by Region, 2020-2034 (USD billion)

8. Global DNA Diagnostics Market, by Application

8.1. Key Findings
8.2. Introduction
- 8.2.1. Global DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
8.3. Cancer Genetics Tests
- 8.3.1. Global DNA Diagnostics Market, by Cancer Genetics Tests, by Region, 2020-2034 (USD billion)
8.4. Infectious Diseases DNA Testing
- 8.4.1. Global DNA Diagnostics Market, by Infectious Diseases DNA Testing, by Region, 2020-2034 (USD billion)
- 8.4.2. CT/NG Diagnostic
  - 8.4.2.1. Global DNA Diagnostics Market, by CT/NG Diagnostic, by Region, 2020-2034 (USD billion)
- 8.4.3. HBV Diagnostic
  - 8.4.3.1. Global DNA Diagnostics Market, by HBV Diagnostic, by Region, 2020-2034 (USD billion)
- 8.4.4. HCV Diagnostic
  - 8.4.4.1. Global DNA Diagnostics Market, by HCV Diagnostic, by Region, 2020-2034 (USD billion)
- 8.4.5. HIV Diagnostic
  - 8.4.5.1. Global DNA Diagnostics Market, by HIV Diagnostic, by Region, 2020-2034 (USD billion)
- 8.4.6. HPV Diagnostic
  - 8.4.6.1. Global DNA Diagnostics Market, by HPV Diagnostic, by Region, 2020-2034 (USD billion)
- 8.4.7. MRSA Diagnostic
  - 8.4.7.1. Global DNA Diagnostics Market, by MRSA Diagnostic, by Region, 2020-2034 (USD billion)
- 8.4.8. TB Diagnostic
  - 8.4.8.1. Global DNA Diagnostics Market, by TB Diagnostic, by Region, 2020-2034 (USD billion)
- 8.4.9. Others
  - 8.4.9.1. Global DNA Diagnostics Market, by Others, by Region, 2020-2034 (USD billion)
8.5. Newborn Genetic Screening
- 8.5.1. Global DNA Diagnostics Market, by Newborn Genetic Screeningc, by Region, 2020-2034 (USD billion)
8.6. Preimplantation & Reproductive Diagnosis
- 8.6.1. Global DNA Diagnostics Market, by Preimplantation & Reproductive Diagnosis, by Region, 2020-2034 (USD billion)
8.7. Non-Infectious Diseases DNA Testing
- 8.7.1. Global DNA Diagnostics Market, by Non-Infectious Diseases DNA Testing, by Region, 2020-2034 (USD billion)
- 8.7.2. Cardiovascular Diseases
  - 8.7.2.1. Global DNA Diagnostics Market, by Cardiovascular Diseases, by Region, 2020-2034 (USD billion)
- 8.7.3. CNS & PNS Related
  - 8.7.3.1. Global DNA Diagnostics Market, by CNS & PNS Related, by Region, 2020-2034 (USD billion)
- 8.7.4. Lung, Kidney, Liver & GT Related
  - 8.7.4.1. Global DNA Diagnostics Market, by Lung, Kidney, Liver & GT Related, by Region, 2020-2034 (USD billion)
- 8.7.5. Sensory Diseases
  - 8.7.5.1. Global DNA Diagnostics Market, by Sensory Diseases, by Region, 2020-2034 (USD billion)
- 8.7.6. Skeletal, Connective, Ectodermal & Dermal DNA Testing
  - 8.7.6.1. Global DNA Diagnostics Market, by Skeletal, Connective, Ectodermal & Dermal DNA Testing, by Region, 2020-2034 (USD billion)
8.8. Hematology & Immunology/Identity Diagnostics & Forensics
- 8.8.1. Global DNA Diagnostics Market, by Hematology & Immunology/Identity Diagnostics & Forensics, by Region, 2020-2034 (USD billion)
8.9. Pharmacogenomics/Drug Metabolism
- 8.9.1. Global DNA Diagnostics Market, by Pharmacogenomics/Drug Metabolism, by Region, 2020-2034 (USD billion)
8.10. Prenatal DNA Carrier Screening
- 8.10.1. Global DNA Diagnostics Market, by Prenatal DNA Carrier Screening, by Region, 2020-2034 (USD billion)
8.11. Others
- 8.11.1. Global DNA Diagnostics Market, by Others, by Region, 2020-2034 (USD billion)

9. Global DNA Diagnostics Market, by End User

9.1. Key Findings
9.2. Introduction
- 9.2.1. Global DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
9.3. Diagnostic Laboratories
- 9.3.1. Global DNA Diagnostics Market, by Diagnostic Laboratories, by Region, 2020-2034 (USD billion)
9.4. Hospitals & clinics
- 9.4.1. Global DNA Diagnostics Market, by Hospitals & clinics, by Region, 2020-2034 (USD billion)
9.5. Others
- 9.5.1. Global DNA Diagnostics Market, by Others, by Region, 2020-2034 (USD billion)

10. Global DNA Diagnostics Market, by Geography

10.1. Key Findings
10.2. Introduction
- 10.2.1. DNA Diagnostics Market Assessment, By Geography, 2020-2034 (USD billion)
10.3. DNA Diagnostics Market - North America
- 10.3.1. North America: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
- 10.3.2. North America: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
- 10.3.3. North America: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
- 10.3.4. North America: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
- 10.3.5. North America: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
- 10.3.7. DNA Diagnostics Market - U.S.
  - 10.3.7.1. U.S.: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
  - 10.3.7.2. U.S.: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
  - 10.3.7.3. U.S.: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
  - 10.3.7.4. U.S.: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
  - 10.3.7.5. U.S.: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
- 10.3.8. DNA Diagnostics Market - Canada
  - 10.3.8.1. Canada: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
  - 10.3.8.2. Canada: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
  - 10.3.8.3. Canada: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
  - 10.3.8.4. Canada: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
  - 10.3.8.5. Canada: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
10.4. DNA Diagnostics Market - Europe
- 10.4.1. Europe: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
- 10.4.2. Europe: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
- 10.4.3. Europe: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
- 10.4.4. Europe: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
- 10.4.5. Europe: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
- 10.4.6. DNA Diagnostics Market - UK
  - 10.4.6.1. UK: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
  - 10.4.6.2. UK: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
  - 10.4.6.3. UK: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
  - 10.4.6.4. UK: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
  - 10.4.6.5. UK: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
- 10.4.7. DNA Diagnostics Market - France
  - 10.4.7.1. France: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
  - 10.4.7.2. France: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
  - 10.4.7.3. France: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
  - 10.4.7.4. France: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
  - 10.4.7.5. France: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
- 10.4.8. DNA Diagnostics Market - Germany
  - 10.4.8.1. Germany: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
  - 10.4.8.2. Germany: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
  - 10.4.8.3. Germany: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
  - 10.4.8.4. Germany: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
  - 10.4.8.5. Germany: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
- 10.4.9. DNA Diagnostics Market - Italy
  - 10.4.9.1. Italy: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
  - 10.4.9.2. Italy: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
  - 10.4.9.3. Italy: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
  - 10.4.9.4. Italy: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
  - 10.4.9.5. Italy: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
- 10.4.10. DNA Diagnostics Market - Spain
  - 10.4.10.1. Spain: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
  - 10.4.10.2. Spain: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
  - 10.4.10.3. Spain: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
  - 10.4.10.4. Spain: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
  - 10.4.10.5. Spain: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
- 10.4.11. DNA Diagnostics Market - Netherlands
  - 10.4.11.1. Netherlands: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
  - 10.4.11.2. Netherlands: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
  - 10.4.11.3. Netherlands: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
  - 10.4.11.4. Netherlands: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
  - 10.4.11.5. Netherlands: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
- 10.4.12. DNA Diagnostics Market - Russia
  - 10.4.12.1. Russia: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
  - 10.4.12.2. Russia: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
  - 10.4.12.3. Russia: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
  - 10.4.12.4. Russia: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
  - 10.4.12.5. Russia: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
- 10.4.13. DNA Diagnostics Market - Rest of Europe
  - 10.4.13.1. Rest of Europe: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
  - 10.4.13.2. Rest of Europe: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
  - 10.4.13.3. Rest of Europe: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
  - 10.4.13.4. Rest of Europe: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
  - 10.4.13.5. Rest of Europe: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
10.5. DNA Diagnostics Market - Asia Pacific
- 10.5.1. Asia Pacific: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
- 10.5.2. Asia Pacific: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
- 10.5.3. Asia Pacific: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
- 10.5.4. Asia Pacific: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
- 10.5.5. Asia Pacific: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
- 10.5.6. DNA Diagnostics Market - China
  - 10.5.6.1. China: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
  - 10.5.6.2. China: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
  - 10.5.6.3. China: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
  - 10.5.6.4. China: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
  - 10.5.6.5. China: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
- 10.5.7. DNA Diagnostics Market - India
  - 10.5.7.1. India: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
  - 10.5.7.2. India: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
  - 10.5.7.3. India: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
  - 10.5.7.4. India: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
  - 10.5.7.5. India: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
- 10.5.8. DNA Diagnostics Market - Malaysia
  - 10.5.8.1. Malaysia: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
  - 10.5.8.2. Malaysia: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
  - 10.5.8.3. Malaysia: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
  - 10.5.8.4. Malaysia: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
  - 10.5.8.5. Malaysia: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
- 10.5.9. DNA Diagnostics Market - Japan
  - 10.5.9.1. Japan: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
  - 10.5.9.2. Japan: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
  - 10.5.9.3. Japan: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
  - 10.5.9.4. Japan: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
  - 10.5.9.5. Japan: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
- 10.5.10. DNA Diagnostics Market - Indonesia
  - 10.5.10.1. Indonesia: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
  - 10.5.10.2. Indonesia: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
  - 10.5.10.3. Indonesia: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
  - 10.5.10.4. Indonesia: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
  - 10.5.10.5. Indonesia: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
- 10.5.11. DNA Diagnostics Market - South Korea
  - 10.5.11.1. South Korea: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
  - 10.5.11.2. South Korea: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
  - 10.5.11.3. South Korea: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
  - 10.5.11.4. South Korea: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
  - 10.5.11.5. South Korea: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
- 10.5.12. DNA Diagnostics Market - Australia
  - 10.5.12.1. Australia: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
  - 10.5.12.2. Australia: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
  - 10.5.12.3. Australia: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
  - 10.5.12.4. Australia: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
  - 10.5.12.5. Australia: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
- 10.5.13. DNA Diagnostics Market - Rest of Asia Pacific
  - 10.5.13.1. Rest of Asia Pacific: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
  - 10.5.13.2. Rest of Asia Pacific: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
  - 10.5.13.3. Rest of Asia Pacific: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
  - 10.5.13.4. Rest of Asia Pacific: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
  - 10.5.13.5. Rest of Asia Pacific: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
10.6. DNA Diagnostics Market - Middle East & Africa
- 10.6.1. Middle East & Africa: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
- 10.6.2. Middle East & Africa: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
- 10.6.3. Middle East & Africa: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
- 10.6.4. Middle East & Africa: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
- 10.6.5. Middle East & Africa: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
- 10.6.6. DNA Diagnostics Market - Saudi Arabia
  - 10.6.6.1. Saudi Arabia: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
  - 10.6.6.2. Saudi Arabia: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
  - 10.6.6.3. Saudi Arabia: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
  - 10.6.6.4. Saudi Arabia: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
  - 10.6.6.5. Saudi Arabia: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
- 10.6.7. DNA Diagnostics Market - UAE
  - 10.6.7.1. UAE: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
  - 10.6.7.2. UAE: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
  - 10.6.7.3. UAE: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
  - 10.6.7.4. UAE: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
  - 10.6.7.5. UAE: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
- 10.6.8. DNA Diagnostics Market - Israel
  - 10.6.8.1. Israel: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
  - 10.6.8.2. Israel: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
  - 10.6.8.3. Israel: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
  - 10.6.8.4. Israel: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
  - 10.6.8.5. Israel: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
- 10.6.9. DNA Diagnostics Market - South Africa
  - 10.6.9.1. South Africa: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
  - 10.6.9.2. South Africa: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
  - 10.6.9.3. South Africa: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
  - 10.6.9.4. South Africa: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
  - 10.6.9.5. South Africa: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
- 10.6.10. DNA Diagnostics Market - Rest of Middle East & Africa
  - 10.6.10.1. Rest of Middle East & Africa: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
  - 10.6.10.2. Rest of Middle East & Africa: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
  - 10.6.10.3. Rest of Middle East & Africa: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
  - 10.6.10.4. Rest of Middle East & Africa: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
  - 10.6.10.5. Rest of Middle East & Africa: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
10.7. DNA Diagnostics Market - Latin America
- 10.7.1. Latin America: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
- 10.7.2. Latin America: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
- 10.7.3. Latin America: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
- 10.7.4. Latin America: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
- 10.7.5. Latin America: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
- 10.7.6. DNA Diagnostics Market - Mexico
  - 10.7.6.1. Mexico: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
  - 10.7.6.2. Mexico: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
  - 10.7.6.3. Mexico: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
  - 10.7.6.4. Mexico: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
  - 10.7.6.5. Mexico: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
- 10.7.7. DNA Diagnostics Market - Brazil
  - 10.7.7.1. Brazil: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
  - 10.7.7.2. Brazil: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
  - 10.7.7.3. Brazil: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
  - 10.7.7.4. Brazil: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
  - 10.7.7.5. Brazil: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
- 10.7.8. DNA Diagnostics Market - Argentina
  - 10.7.8.1. Argentina: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
  - 10.7.8.2. Argentina: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
  - 10.7.8.3. Argentina: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
  - 10.7.8.4. Argentina: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
  - 10.7.8.5. Argentina: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
- 10.7.9. DNA Diagnostics Market - Rest of Latin America
  - 10.7.9.1. Rest of Latin America: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
  - 10.7.9.2. Rest of Latin America: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
  - 10.7.9.3. Rest of Latin America: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
  - 10.7.9.4. Rest of Latin America: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
  - 10.7.9.5. Rest of Latin America: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)

11. Competitive Landscape

11.1. Expansion and Acquisition Analysis
- 11.1.1. Expansion
- 11.1.2. Acquisitions
11.2. Partnerships/Collaborations/Agreements/Exhibitions

12. Company Profiles

12.1. Abbott
- 12.1.1. Company Overview
- 12.1.2. Financial Performance
- 12.1.3. Product Benchmarking
- 12.1.4. Recent Development
12.2. Agilent Technologies, Inc.
- 12.2.1. Company Overview
- 12.2.2. Financial Performance
- 12.2.3. Product Benchmarking
- 12.2.4. Recent Development
12.3. Avalon GloboCare Corp.
- 12.3.1. Company Overview
- 12.3.2. Financial Performance
- 12.3.3. Product Benchmarking
- 12.3.4. Recent Development
12.4. Beckman Coulter, Inc.
- 12.4.1. Company Overview
- 12.4.2. Financial Performance
- 12.4.3. Product Benchmarking
- 12.4.4. Recent Development
12.5. Bio-Rad Laboratories, Inc.
- 12.5.1. Company Overview
- 12.5.2. Financial Performance
- 12.5.3. Product Benchmarking
- 12.5.4. Recent Development
12.6. Cepheidc
- 12.6.1. Company Overview
- 12.6.2. Financial Performance
- 12.6.3. Product Benchmarking
- 12.6.4. Recent Development
12.7. F. Hoffmann-La Roche Ltd
- 12.7.1. Company Overview
- 12.7.2. Financial Performance
- 12.7.3. Product Benchmarking
- 12.7.4. Recent Development
12.8. GE HealthCare
- 12.8.1. Company Overview
- 12.8.2. Financial Performance
- 12.8.3. Product Benchmarking
- 12.8.4. Recent Development
12.9. Hologic, Inc.
- 12.9.1. Company Overview
- 12.9.2. Financial Performance
- 12.9.3. Product Benchmarking
- 12.9.4. Recent Development
12.10. Illumina, Inc.
- 12.10.1. Company Overview
- 12.10.2. Financial Performance
- 12.10.3. Product Benchmarking
- 12.10.4. Recent Development
12.11. Siemens Healthcare Private Limited
- 12.11.1. Company Overview
- 12.11.2. Financial Performance
- 12.11.3. Product Benchmarking
- 12.11.4. Recent Development
12.12. Thermo Fisher Scientific Inc.
- 12.12.1. Company Overview
- 12.12.2. Financial Performance
- 12.12.3. Product Benchmarking
- 12.12.4. Recent Development